Following the news that global biopharmaceutical group Ipsen has implemented a new cell-based test for toxin products, Aesthetics looks at patient perceptions towards animal testing.
Aesthetics reports on the scar treatment conference that took place in Tel Aviv on March 21-22
In the second of a two-part article, Dr Souphiyeh Samizadeh explores the different technologies of dermal fillers and their characteristics to aid product selection.
In the first of a two-part article, Dr Souphiyeh Samizadeh discusses the basic characteristics of hyaluronic acid fillers to aid product selection
Professor Andy Pickett and independent aesthetic business consultant Emma Miller discuss research into the use of botulinum toxin for the treatment of obesity
The textured breast implants that have been linked to a rare form of atypical lymphoma, Breast Implant Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) have now been removed from the European market.
In September, Spanish pharmaceutical company Almirall acquired Allergan’s US medical dermatology unit portfolio by using a €400 million bridge loan. It acquired brands Aczone (dapsone), Tazorac (tazarotene), Azelex (azelaic acid) and Cordran Tape (fludroxycortide).
